Latest Articles
Women with endometriosis four times more likely to develop cancer - MSN
Women with endometriosis four times more likely to develop cancer MSN
Published: April 28, 2025, 7:45 a.m.
Sex Hormones Increase Endometrial Cancer Risk in Postmenopausal Women: Study - Medical Dialogues
Sex Hormones Increase Endometrial Cancer Risk in Postmenopausal Women: Study Medical Dialogues
Published: April 25, 2025, 3 p.m.
Evaluation of Pyroptosis-Associated Genes in Endometrial Cancer Utilizing a 101-Combination Machine Learning Framework and Multi-Omics Data - Frontiers
Evaluation of Pyroptosis-Associated Genes in Endometrial Cancer Utilizing a 101-Combination Machine Learning Framework and Multi-Omics Data Frontiers
Published: April 25, 2025, 10:08 a.m.
New biomarkers identified for early detection of gynecological cancer - News-Medical
New biomarkers identified for early detection of gynecological cancer News-Medical
Published: April 23, 2025, 4:35 p.m.
AI diagnoses endometrial cancer with high accuracy - Lab + Life Scientist
AI diagnoses endometrial cancer with high accuracy Lab + Life Scientist
Published: April 23, 2025, 1:24 a.m.
Dr Agustí Garcia on Patient Eligibility for Evaluating Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer - OncLive
Dr Agustí Garcia on Patient Eligibility for Evaluating Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer OncLive
Published: April 21, 2025, 7:21 p.m.
Mayo Clinic Q and A: Uterine polyps rarely are cancerous - Mayo Clinic News Network
Mayo Clinic Q and A: Uterine polyps rarely are cancerous Mayo Clinic News Network
Published: April 21, 2025, 3 p.m.
Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer - OncLive
Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer OncLive
Published: April 21, 2025, 1:17 p.m.
Cadonilimab-Lenvatinib Combo Exhibits Activity in Advanced Endometrial Cancer - Oncology Nurse Advisor
Cadonilimab-Lenvatinib Combo Exhibits Activity in Advanced Endometrial Cancer Oncology Nurse Advisor
Published: April 21, 2025, 4 a.m.
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer - OncLive
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer OncLive
Published: April 18, 2025, 3:54 p.m.
Link copied to clipboard!